NVLX "We are honored that TD2 and Dr. Von Hoff wil
Post# of 1086
Posted On: 04/01/2014 2:25:58 PM
NVLX "We are honored that TD2 and Dr. Von Hoff will play a pivotal role in the development of our treatment for patients with advanced pancreatic cancer that combines the proprietary Cell-in-a-Box® live-cell encapsulation technology with the cancer drug ifosfamide.
http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U
http://www.stockwatch.com/News/Item.aspx?bid=...p;region=U
(0)
(0)PharmaCyte Biotech Inc. (PMCB) Stock Research Links
Scroll down for more posts ▼